A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs

By Crisà Elena   Venturino Ermanno   Passera Roberto   Prina Marco   Schinco Piercarla   Borchiellini Alessandra   Giai Valentina   Ciocca Vasino Maria   Bazzan Mario   Vaccarino Antonella   Boccadoro Mario   Ferrero Dario  

Annals of Hematology, Vol. 89, Iss. 7, 2010-07 ,pp. : 691-699

Springer Publishing Company

Access to resources Recommend Favorite

Polycythemia vera-related MDS in a dog

By Nassiri Seyed  

Comparative Clinical Pathology, Vol. 19, Iss. 6, 2010-12 ,pp. : 627-630

Springer Publishing Company

Access to resources Recommend Favorite

Defective expression of the SHP-1 phosphatase in polycythemia vera

By Wickrema A.   Chen F.   Namin F.   Yi T.   Ahmad S.   Uddin S.   Chen Y.-H.   Feldman L.   Stock W.   Hoffman R.   Platanias L.C.  

Experimental Hematology, Vol. 27, Iss. 7, 1999-07 ,pp. : 1124-1132

Elsevier

Access to resources Recommend Favorite

Synovial tumefactive extramedullary hematopoiesis associated to polycythemia vera

By Alvarez-Argüelles Cabrera Hugo   Carrasco Juan José   García Castro María   González Gaitano Manuel   Bonilla Arjona Alfonso   Díaz-Flores Lucio  

Virchows Archiv, Vol. 450, Iss. 1, 2007-01 ,pp. : 109-113

Springer Publishing Company

Access to resources Recommend Favorite

Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis

By Silver Richard T   Kiladjian Jean-Jacques   Hasselbalch Hans Carl  

Expert Review of Hematology, Vol. 6, Iss. 1, 2013-02 ,pp. : 49-58

Informa Healthcare

Access to resources Recommend Favorite